Get the Stockscreener App
1.65
0.00%
0.00
Pre-market:
1.66
0.01
+0.61%
Quince Therapeutics Inc stock is traded at $1.65, with a volume of 129.84K.
It is up +0.00% in the last 24 hours and up +1.23% over the past month.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
See More
Previous Close:
$1.65
Open:
$1.64
24h Volume:
129.84K
Relative Volume:
0.50
Market Cap:
$88.63M
Revenue:
-
Net Income/Loss:
$-31.39M
P/E Ratio:
-1.9643
EPS:
-0.84
Net Cash Flow:
$-18.45M
1W Performance:
-6.25%
1M Performance:
+1.23%
6M Performance:
+50.00%
1Y Performance:
+1.85%
1-Day Range:
$1.597
$1.68
1-Week Range:
$1.597
$1.875
52-Week Range:
$0.7203
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Name
Quince Therapeutics Inc
Sector
Industry
Phone
415-910-5717
Address
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Compare QNCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.65 | 88.63M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-24-25 | Initiated | Oppenheimer | Outperform |
Quince Therapeutics Inc Stock (QNCX) Latest News
What indicators show strength in Quince Therapeutics Inc.2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Will earnings trigger a reversal in Quince Therapeutics Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Is Quince Therapeutics Inc. stock positioned for digital transformationTreasury Yields & Daily Market Momentum Tracking - newser.com
How Quince Therapeutics Inc. stock performs in rising dollar environmentTrade Volume Summary & Safe Entry Zone Tips - newser.com
Will Quince Therapeutics Inc. stock recover faster than peers2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Quince Therapeutics Inc. stock double in next 5 yearsIPO Watch & Entry Point Strategy Guides - newser.com
Statistical indicators supporting Quince Therapeutics Inc.’s strengthJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Why retail investors favor Quince Therapeutics Inc. stockJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
How analysts rate Quince Therapeutics Inc. stock todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Is Quince Therapeutics Inc. stock cheap compared to fundamentalsWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Combining machine learning predictions for Quince Therapeutics Inc.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Quince Therapeutics Inc. stock volume spike explained2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Is Quince Therapeutics Inc. showing signs of accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is Quince Therapeutics Inc. stock ready for a breakoutMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Market reaction to Quince Therapeutics Inc.’s recent newsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
How to forecast Quince Therapeutics Inc. trends using time seriesDip Buying & Verified Momentum Stock Watchlist - newser.com
Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Quince Therapeutics Inc Stock (QNCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):